Lozen Pharma Private Limited

Develops and produces medicated confectionery products, including lozenges, inhalers, candies, pain relief products, and more.

2009 | Haveri, Karnataka (India) | Active
Last Updated: January 02, 2025

Lozen Pharma Profile

Key Indicators

  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 30.80 Cr
  • Company Age 16 Year, 17 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.17 Cr
  • Satisfied Charges ₹ 1.45 Cr
  • Revenue Growth 69.08%
  • Profit Growth 660.67%
  • Ebitda 1305.79%
  • Net Worth 24.24%
  • Total Assets 14.87%

About Lozen Pharma

Lozen Pharma Private Limited (LPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 January 2009 and has a history of 16 years. Its registered office is in Haveri, Karnataka, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 30.80 Cr.

The company currently has active open charges totaling ₹11.17 Cr. The company has closed loans amounting to ₹1.45 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Lozen Pharma Private Limited India is Renuka Gaggar as COMPANY SECRETARY. Gautam Ashra, Jugal Parekh, and Arjun Ashra serve as directors at the Company.

Company Details

  • Location

    Haveri, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239KA2009PTC068381

  • Company No.

    068381

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Jan 2009

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma

What products or services does Lozen Pharma Private Limited offer?

Lozen Pharma Private Limited offers a wide range of products and services, including Candy & Jelly, Flavoured Candies, Common Disease Medicines, Cough Syrup.

Who are the key members and board of directors at Lozen Pharma?

Executive Team (1)

Name Designation Appointment Date Status
Renuka Gaggar Country flag representing In Company Secretary 13-Jun-2019 Current

Board Members (3)

Name Designation Appointment Date Status
Jugal Parekh Country flag representing In Director 27-Nov-2020 Current
Gautam Ashra Country flag representing In Director 11-Aug-2023 Current
Arjun Ashra Country flag representing In Director 25-Oct-2016 Current

Financial Performance of Lozen Pharma.

Lozen Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.08% increase. The company also saw a substantial improvement in profitability, with a 660.67% increase in profit. The company's net worth Soared by an impressive increase of 24.24%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
69.08%
Revenue from Operations
92.92%
Total Assets
14.87%
Profit or Loss
660.67%
Net Worth
24.24%
EBITDA
1305.79%

What is the Ownership and Shareholding Structure of Lozen Pharma?

In 2022, Lozen Pharma had a promoter holding of 76.31% and a public holding of 23.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹11.17 Cr

Satisfied Charges

₹1.45 Cr

Charges Breakdown by Lending Institutions

  • Others : 11.17 Cr

Latest Charge Details

Date Lender Amount Status
21 Jun 2024 Others ₹11.17 Cr Open
18 Aug 2016 Others ₹1.00 Cr Satisfied
22 Dec 2011 Karnataka State Financial Corporation ₹4.50 M Satisfied

How Many Employees Work at Lozen Pharma?

Lozen Pharma has a workforce of 88 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lozen Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Lozen Pharma

Recent activity within the organization

  • Annual General Meeting

    Lozen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Charges

    A charge with Others amounted to Rs. 11.17 Cr with Charge ID 100953641 was registered on 21 Jun 2024.

    21 Jun 2024

  • Balance Sheet

    Lozen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Gautam Rasiklal Ashra was appointed as a Director was appointed as a Director on 11 Aug 2023 & has been associated with this company since 1 year 5 months .

    11 Aug 2023

  • Charges

    A charge registered on 18 Aug 2016 via Charge ID 100052284 with Others was fully satisfied on 09 Jun 2021.

    09 Jun 2021

  • Director Appointment

    Jugal Parekh was appointed as a Director was appointed as a Director on 27 Nov 2020 & has been associated with this company since 4 years 2 months .

    27 Nov 2020

Frequently asked questions

  • Lozen Pharma Private Limited was incorporated on 14 Jan 2009.

  • The authorized share capital of Lozen Pharma Private Limited is ₹ 40.00 Cr and paid-up capital is ₹ 30.80 Cr.

  • Currently 4 directors are associated with Lozen Pharma Private Limited.

    • Gautam Rasiklal Ashra
    • Jugal Parekh
    • Arjun Gautam Ashra
    • Renuka Vinod Gaggar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Lozen Pharma Private Limited is Kssidc Industrial Estate Shiggaon Road, India, Savanur, Karnataka, 581118.

  • The corporate identification number (CIN) of Lozen Pharma Private Limited is U24239KA2009PTC068381 and the company number is 068381 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Lozen Pharma Private Limited is https://www.lozenpharma.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Lozen Pharma Private Limited has risen by 69.08%.

  • As Per 2022 financial reports, 88 employees are currently employed by Lozen Pharma Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Lozen Pharma Private Limited has experienced an upsurge of 24.24%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Lozen Pharma Private Limited amount to ₹ 11.17 Cr.

  • The most recent Balance Sheet for Lozen Pharma Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development